How aging impacts axon regeneration after CNS injury is not known. We assessed the impact of age on axon regeneration induced by Pten deletion in corticospinal and rubrospinal neurons, two neuronal populations with distinct innate regenerative abilities. As in young mice, Pten deletion in older mice remains effective in preventing axotomy-induced decline in neuron-intrinsic growth state, as assessed by mTOR activity, neuronal soma size, and axonal growth proximal to a spinal cord injury. However, axonal regeneration distal to injury is greatly diminished, accompanied by increased expression of astroglial and inflammatory markers at the injury site. Thus, the mammalian CNS undergoes an age-dependent decline in axon regeneration, as revealed when neuron-intrinsic growth state is elevated. These results have important implications for developing strategies to promote axonal repair after CNS injuries or diseases, which increasingly affect middle-aged to aging populations.
In Brief
Working on two different axonal pathways, Geoffroy et al. show an agedependent decline in axon regeneration after injury in the adult mammalian CNS. Their data implicate changes in neuronextrinsic influences at the injury site in this age-dependent decline.
INTRODUCTION
Spinal cord injury is increasingly inflicted in older populations (DeVivo and Chen, 2011; Singh et al., 2014) . The average age of incidence for spinal cord injury has risen substantially in recent years, from 29 in the 1970s to 42 since 2010 in the United States (National Spinal Cord Injury Statistical Center) due to an increasingly active older population. This changing demographic calls for a critical need to better understand how aging impacts recovery and repair after spinal cord injury. Despite the central importance of axon regeneration in spinal cord repair (Bradke and Marín, 2014; Silver et al., 2015) , how aging impacts CNS axon regeneration is not well understood, largely because CNS axons, even in young adult mammals, naturally have a very limited ability to regenerate after injury. The recent discovery of neuron-intrinsic factors whose manipulation reproducibly promotes axon regeneration in the CNS (Lu et al., 2014) has made it possible to address this question.
To assess the impact of increased age on CNS axon regeneration, we asked whether genetic Pten deletion, a molecular manipulation that promotes significant CNS axon regeneration in young adult mammals (Liu et al., 2010; Park et al., 2008) , remains effective in older animals (up to 12-18 months old). PTEN is a negative regulator of the mTOR (mammalian target of rapamycin) signaling pathway (Ma and Blenis, 2009 ). Neuronal mTOR activity undergoes development-dependent decline and is further downregulated after axonal injury in the adult CNS (Liu et al., 2010; Park et al., 2008) . Genetic Pten deletion in young animals prevents axotomy-induced reduction of mTOR activity and promotes the regeneration of both retinal ganglion and corticospinal tract (CST) axons after CNS injury (Liu et al., 2010; Park et al., 2008) .
Here, we examined the effect of age on axon regeneration in the mammalian CNS using both the CST and the rubrospinal tract (RST) as the model systems. Our data indicate that aging may dissociate neuron-intrinsic growth state and axon regeneration in Pten-deleted mice, neuronal properties previously considered inseparable. Specifically, while Pten deletion in middle-aged to aging mice continues to promote a neuron-intrinsic growth state as assessed by mTOR activity, neuronal soma size, and axonal growth proximal to a spinal cord injury, it loses effectiveness in promoting axon regeneration distal to the injury as compared with young mice. These results reveal an agedependent decline in CNS axon regeneration and implicate changes in neuron-extrinsic influences in this age-dependent decline.
RESULTS

The Diminishing Effect of Pten Deletion on Corticospinal Axon Regeneration with Increasing Age
We previously observed significant CST axon regeneration after a dorsal hemisection (DH) spinal cord injury in young Pten-deleted mice (Liu et al., 2010) . In that study, Pten deletion was initiated at postnatal day 1 (P1) by unilateral cortical AAVCre injection into the sensorimotor cortex of homozygous Pten conditional mutant (Pten f/f ) mice, and the injury was performed at 6 weeks of age. To systematically examine the impact of age on the CST regeneration-promoting effect of Pten deletion, we induced Pten deletion by AAV-Cre injection (along with AAV-GFP controls) in P1, 4-to 6-week-old, 10-week-old, and 12-to 18-month-old PTEN f/f mice. Four to six weeks later, we performed a T8 dorsal hemisection injury, which severs virtually all labeled CST axons Liu et al., 2010; Zheng et al., 2006) . Axon tracer biotinylated dextran amine (BDA) was injected into the sensorimotor cortex 4 weeks later, and the mice were killed and analyzed for BDA-traced CST axons two additional weeks later (thus, a survival period of 6 weeks after injury). After a penetrating injury in mice, a glial fibrillary acidic protein (GFAP) sparse injury epicenter is surrounded by GFAP-dense areas reflecting reactive astrogliosis immediately rostral and caudal to the epicenter (Herrmann et al., 2010) . Rostral to injury, CST axons in control mice exhibited typical retraction (or dieback) from the injury site for a few hundred micrometers (Figures 1A and 1A 0 ), as quantified with axon density index (BDA labeling density at defined distances normalized to that at 1.5 mm rostral to injury) ( Figure 1F ). As expected (Liu et al., 2010) , there was a significant increase in axon density immediately rostral to the injury site in mice when Pten deletion was initiated at P1 ( Figures 1B, 1B 0 , and 1F). That CST axons are detected all the way to the very rostral edge of the lesion epicenter is a hallmark of the effect of Pten deletion and has been shown to result from enhanced CST axon regrowth and not reduced axonal dieback in younger mice (Liu et al., 2010) . Interestingly, initiating Pten deletion at 4-6 weeks, 10 weeks, or even 12-18 months of age led to similar increases of CST axon density immediately rostral to the injury site, such that no significant differences were observed among different age groups ( Figures 1B-1E 0 and 1F). To rule out the possibility that Pten deletion only in older mice alters axonal dieback early after injury, we compared CST axon labeling rostral to injury between 12-month-old control and Pten-deleted mice that carry the ROSA26-lsl-tdTomato genetic reporter (Madisen et al., 2010) . There was no significant difference in rostral CST axon labeling, as assessed with either BDA or the genetically encoded tdTomato tracer, at 10 days after a dorsal hemisection spinal cord injury between old control and age-matched Pten deleted mice (Figures S1A-S1C), indicating that Pten deletion does not alter CST axon dieback in old mice. Consequently, the increased CST labeling proximal to the injury site at the later time point most likely reflected axonal growth, but not less axonal dieback, in Pten-deleted aging mice. Together, these data indicate that Pten deletion promotes rostral CST axon growth toward a spinal cord injury site independently of age.
In stark contrast, CST axon regeneration caudal to the injury site in Pten-deleted mice varied greatly with age. As expected (Liu et al., 2010) , initiating Pten deletion in P1 mice led to significant CST regeneration caudal to injury in young adult mice as compared to controls ( Figures 1B, 1B 0 , 1G, and 1H). At increasing ages of initiating Pten deletion, from P1, 4-6 weeks, 10 weeks, to 12-18 months, CST regeneration caudal to injury (assessed in mice 10-12 weeks older) was increasingly diminished, as quantified by the axon number index (the number of axons within specific distance intervals caudal to injury, normalized against the total number of axons labeled in the medulla) ( Figure 1B-1E 0 and 1G). The 4-to 6-week deletion group had a slight decrease in axon regeneration caudal to injury as compared with the P1 group that did not reach statistical significance (two-way ANOVA). The 10-week group had significantly less axon regeneration at 50, 150, and 250 mm caudal to injury as compared with the P1 group. This decrease in CST regeneration was even more pronounced in the 12-to 18-month group, in which Pten deletion led to little, if any, regeneration. 44% of the P1 deletion group, 21% of the 4-to 6-week group, and 0% of the 10-week or 12-18 month groups presented any axons at 750 mm or more distal to injury (i.e., 750 mm is approximately half of maximal regeneration distance in the P1 group). Plotting the cumulative axon number index past this 0.75-mm mark confirmed a clear trend for diminishing CST regeneration at increasing ages ( Figure 1H ). Thus, while Pten deletion in older mice remains effective in eliciting CST axon growth rostral to a spinal cord injury, its effect on promoting CST regeneration beyond the injury site is increasingly diminished with increasing ages.
The Diminishing Effect of Pten Deletion on Rubrospinal Axon Regeneration with Increasing Age
To determine whether this age-dependent decline in axon regeneration is unique to the CST or can be extended to another axonal tract, we examined the regeneration of another descending motor tract, the rubrospinal tract (RST). The RST possesses a higher innate regenerative ability than the CST (Blesch and Tuszynski, 2009 ). We performed targeted injections of AAVCre-GFP (or AAV-GFP as control) into the vicinity of the right red nucleus of 4-week-old or 7-to 8-month-old homozygous Pten conditional mutant (Pten f/f ) mice (Groszer et al., 2001 ). Four weeks later, mice underwent a C4 dorsolateral funiculus crush (DLF) injury to unilaterally and completely axotomize the RST similarly to as previously described (Hilton et al., 2013) , followed by an 8-week survival period. Immunoreactivity to GFP was used as the axonal tracer, with the advantage over BDA that GFP-labeled rubrospinal neurons had presumably sustained Pten deletion.
In control AAV-GFP-injected control mice, the injured rubrospinal tract underwent characteristic dieback from the lesion site (Figures 2A-2B 00 ). In contrast, when Pten deletion was initiated at 4 weeks of age, the main RST bundle extended into the lesion epicenter ( Figures 2C-2C 00 and 2E), and the axon number index at the injury center was significantly higher than controls (all normalized to 1.5 mm rostral to lesion) ( Figure 2E ). Whereas in control mice there was no RST axon detected at or beyond 1.0 mm caudal to injury, in Pten-deleted mice, RST axons were found to extend up to 1.5 mm caudally to injury 00 and 2F). Injured RST axons took a route to grow laterally toward the injury site in the gray matter following Pten deletion (as seen on the horizontal sections in Figures 2C-2C 00 ). These data demonstrate that, when initiated at a young age (4 weeks), Pten deletion can efficiently promote RST regeneration after injury.
When Pten deletion was initiated at 7-8 months of age, a substantial decrease in RST regeneration caudal to the injury site was observed as compared with the 4-week group ( Figures  2D-2D 00 , 2F, and 2H). At 0.5 mm caudal to injury, the axon number index in the 7-to 8-month deletion group was not significantly different from (non Pten-deleted) control mice but was significantly lower than that of the 4-week group ( Figure 2F ). This number dropped to zero, with no GFP-positive axons observed at or beyond 1 mm caudal to injury ( Figure 2H ). Nevertheless, Pten deletion resulted in a significantly higher axon (G) Quantification of caudal CST axon regeneration. The data for controls were zeros or close to zeros with essentially no error bars. Two-way ANOVA followed by Bonferroni's post hoc test: *p < 0.05, **p < 0.01, and ***p < 0.001. Green *, P1 and 4-6w versus 12-18 m; green @, P1 versus 12-18m; blue *, P1 and 4-6w versus 10w; blue @, P1 versus 10w. N = 14 (P1 Ctrl); 8 (4-to 6-week Ctrl); 5 (12-to 18-month Ctrl); 11 (P1 KO); 14 (4-to 6-week KO); 4 (10-week KO); 12 (12-to 18-month KO).
(H) Cumulative axon number index observed past 0.75 mm caudal to injury. See also Figure S1 .
number index irrespective of age when compared with the control groups at 0.5 mm rostral to injury and at the injury epicenter ( Figures 2E and 2G ). Just as for the CST, Pten deletion in old mice did not impact RST axonal dieback, assessed 7 days after injury, when compared with age-matched control wild-type (WT) mice ( Figures S1D-S1F ). Together, these data indicate that as similar to the CST, Pten deletion in older mice remains effective in eliciting rostral RST axon growth toward and into the spinal cord injury site but has a substantially diminished effect on promoting RST regeneration beyond the injury site. (Carter et al., 2008; Kobayashi et al., 1997) and that Pten deletion leads to enlarged soma size in retinal ganglion neurons (Park et al., 2008) . Aging may impact the regeneration-promoting effect of targeting Pten in two different ways. First, Pten deletion in aging mice may not be as effective in respectively. AAV-GFP injection served as the control. Here, we include a 7-8m KO animal with relatively higher GFP labeling (D) to exemplify the lack of caudal axon growth in aged Pten KO animals. Scale bar, 200 mm.
(E) Quantification of RST axon labeling rostral to and at (0.0 mm) the injury site. Two-way ANOVA followed by Bonferroni's post hoc test: *p < 0.05; black *, 4w and 7-8m KO versus 4w and 7-8m WT.
(F) Quantification of caudal RST axon regeneration. Two-way ANOVA followed by Bonferroni's post hoc test: **p < 0.01; red **, 4w KO versus 7-8m KO, 4w WT, and 7-8m WT.
(G) Axon number index observed at the middle of the injury site. This is the same information shown at 0.0 mm from the injury site in (E).
(H) Cumulative axon number index observed at R1 mm caudal to the injury site. N = 8 (4w WT), 8 (7-8m WT), 8 (4w KO), and 8 (7-8m KO). See also Figure S1 .
rescuing axotomy-induced downregulation of mTOR activity and associated cell atrophy. Second, Pten deletion may still rescue axotomy-induced mTOR downregulation and cell atrophy in aging mice, but other factors intrinsic or extrinsic to neurons contribute to regeneration failure. To distinguish these two possibilities, we analyzed the effect of different ages on the ability of Pten deletion to rescue axotomy-induced mTOR downregulation and cell atrophy. The level of p-S6 (phospho-S6 ribosomal protein), an indicator of mTOR activity, is relatively high in the red nuclei compared to the rest of the midbrain in uninjured adult mice , consistent with the purportedly higher innate growth ability of RST neurons. In control AAV-GFP-injected mice, p-S6 levels were significantly reduced in axotomized rubrospinal neurons as compared with uninjured contralateral neurons (Figures 3B and 3G) . This reduction occurred to a similar level in both the 4-week group and the 7-to 8-month group, regardless of GFP labeling ( Figures S2D and S2E ). However, in AAV-Cre-GFP-injected, Pten-deleted mice, GFP-positive rubrospinal neurons did not undergo p-S6 downregulation regardless of age (Figures 3C, 3G, S2D, and S2E) . In contrast, GFP-negative rubrospinal neurons in the same red nuclei, which presumably had not undergone Pten deletion and were thus WT, exhibited a similar level of p-S6 downregulation as in injured, AAV-GFP-injected controls (Figures 3G and S2E) .
In control AAV-GFP-injected mice, massive atrophy of rubrospinal neurons was observed regardless of GFP labeling ( Figures  3B, 3H , and S2F-S2H), as indicated by a reduction in the average cell surface area of NeuN-positive cells in the red nucleus as compared to that of contralateral uninjured neurons (p < 0.05; Figures 3H and S2F ). This occurred regardless of age as there was not a significant difference between the 4-week AAV-GFPinjected group and the 7-to 8-month AAV-GFP-injected group . In contrast, Pten deletion completely prevented rubrospinal cell body atrophy regardless of age (Figures 3H, S2F, S2G, and S2I) .
Similarly, Pten deletion in the corticospinal neurons prevented axotomy-induced p-S6 downregulation and associated cell atrophy (as assessed with soma area) independently of age . Thus, aging does not appear to influence the extent of mTOR activation induced by Pten deletion, at least as assessed with p-S6 immunoreactivity and neuronal soma size. Together, these data indicate that despite the greatly diminished regeneration, Pten deletion remains effective in preventing axotomy-induced downregulation of mTOR activity and associated cell atrophy in both rubrospinal and corticospinal neurons at increased ages.
Increased Expression of Astroglial and Inflammatory Markers at the Injury Site in Older Animals
Because Pten deletion promoted mTOR signaling and axon growth rostral to injury irrespective of age in both the rubrospinal and corticospinal systems, we hypothesized that differences in environmental influences at and around the lesion site could be responsible for the age-dependent decline in axon regeneration beyond the injury site. To provide initial support for this hypothesis, we compared the expression of several well-known markers associated with glia-derived growth inhibition in young and older mice by immunohistochemistry 6-8 weeks after injury such as the astroglial marker GFAP, chondroitin sulfate proteoglycans (CS-56), and the myelin-associated inhibitor Nogo-A (Anderson et al., 2014; Cregg et al., 2014; Geoffroy et al., 2015; Geoffroy and Zheng, 2014) .
There was significantly increased GFAP upregulation around the injury site at 6 weeks after dorsal hemisection injury in the 12-to 18-month deletion group as compared with the 4-to 6-week group in the CST regeneration study (Figures 4A-4C ). We assessed whether this increase in GFAP was a result of increased astrocyte numbers in the vicinity of the lesion site by triple staining for SOX9, GFAP, and Aldh1L1 Pompolo and Harley, 2001; Zhang et al., 2014) and counting the number of SOX9+ cells, which exhibit 98%-99% co-labeling with the astrocyte markers GFAP or Aldh1L1. The number of SOX9+ cells in the vicinity of the lesion site was not different between young and aged mice ( Figure S4N ; images not shown here, but see below), suggesting that increased reaction of individual astrocytes, and not increased astrocyte proliferation, underlies the age-associated increase in GFAP upregulation. Analyses of two additional time points, 7 and 21 days after injury, suggested a more sustained GFAP upregulation in older mice despite similar levels of upregulation early after injury ( Figure S4A ). However, we did not detect significant differences between young and old mice in CS-56 or Nogo-A upregulation at the same three time points after dorsal hemisection injury (Figures 4A -4B 0 , 4D, S4B, and S4C). Similarly, antibodies that recognize the more inhibitory moiety of CSPGs, chondrointin-4-sulfate (C4S; also known as CS-A) (Lin et al., 2011; Wang et al., 2008) or neurocan, did not detect overt differences in their upregulation after injury between the age groups ( Figures S4D-S4K ). Similarly, increased GFAP, but not CS-56, upregulation in close proximity to the injury site was observed in the older mice (7-to 8-month deletion group) as compared with the young mice (4-week deletion group) after dorsolateral funiculus crush in the RST regeneration study (Figures 4E-4G) . As for the CST regeneration study, no difference in the number of SOX9+ astrocytes was observed between the different age groups (Figures S4L-S4N ). Future studies are required to fully characterize the astroglial response in aging mice.
In addition to glia-derived factors, another aspect of neuronextrinsic influences that could impact axon regeneration is the inflammatory response after spinal cord injury (Benowitz and Popovich, 2011) . Indeed, immunoreactivity for CD68, a microglia/ macrophages marker, exhibited a more pronounced upregulation around the injury site 6 weeks after dorsal hemisection in the 12-to 18-month deletion group when compared with the 4-to 6-week group, which was paralleled with a significant increase of CD68-positive cell number in the older mice ( Figures  4H-4J) . Together, these results indicate that both astroglial and macrophage responses to injury are higher or more sustained in older mice than in young mice, offering possible explanations for the diminished axon regeneration through and beyond the injury site in aging mice.
DISCUSSION
Here, we studied the impact of age and aging on axon regeneration in the adult mammalian CNS. Our results reveal an agedependent decline in CNS axon regeneration in Pten-deleted mice. However, Pten deletion in older animals remains effective in elevating neuron-intrinsic growth state as assessed by mTOR activity, neuronal soma size, and axonal growth proximal to the injury site. These observations support the hypothesis that PTEN inhibits neuronal growth state independently of age in the mammalian CNS. This dichotomy in the effects of Pten deletion on neuronal growth state versus axon regeneration in middle-aged to aging mice implicates neuron-extrinsic influences at and around the injury site as at least one underlying mechanism for this age-dependent decline in regeneration.
An important conclusion from this study is that at increased age, the regeneration-promoting effect of Pten deletion is greatly diminished in both the corticospinal and rubrospinal tracts. Although CST and RST differ significantly in their innate regenerative abilities, the models employed here to study their regeneration differ significantly (thoracic dorsal hemisection versus cervical dorsolateral funiculus crush), and the two axonal tracts were studied in two different laboratories (the CST in B.Z.'s lab and the RST in W.T.'s lab), strikingly similar results were found, indicating the general applicability of our findings. The survival period after injury in our experiments was 6 weeks for the CST and 8 weeks for the RST. It is possible that aging simply slows the speed of axon regeneration due to a more challenging environment, and if so, significant regeneration caudal to injury remains possible in aging mice with a much longer survival period than the ones tested here (Du et al., 2015) . However, the conclusion that aging diminishes the regeneration-promoting effect of Pten deletion in the CNS continues to hold.
Combined with the rescue of axotomy-induced mTOR downregulation and cell atrophy, the robust axon growth rostral to injury provides strong evidence that Pten-deleted neurons, even at an advanced age, possess a high level of axon growth ability. Thus, instead of a lack of neuron-intrinsic growth potential (Jaerve et al., 2012) , as we had originally anticipated, our data implicate an increased level of negative environmental influence at the injury site in aging mice as at least one underlying mechanism for regeneration failure. It should be noted that a greater inhibitory effect might also be mediated by an enhanced response to the inhibitory environment due to changes in receptor compositions and concentrations at the neuronal or axonal surface, which are neuron intrinsic in nature. In addition, changes in other aspects of neuron-intrinsic growth state in aging neurons could have escaped detection with the limited measures in our study. It is entirely possible that manipulating other neuron-intrinsic pathways in combination with Pten deletion may lead to significantly more regeneration despite any increased negative extrinsic influences in the aging CNS.
Given that PTEN inhibits axon regeneration independently of age in Caenorhabditis elegans (Byrne et al., 2014) , the age independence of PTEN's inhibitory effect on neuron-intrinsic growth state appears to be evolutionarily conserved, except that in the aging mammalian CNS, additional inhibitory mechanisms at the injury site may become more prevalent in determining the outcome of regeneration. Consistent with our observation of increased GFAP upregulation at the spinal cord injury site in aging mice, previous studies associated aging with increased GFAP expression in uninjured brain or increased GFAP upregulation following brain injury and stroke (Badan et al., 2003; O'Callaghan and Miller, 1991; Sandhir et al., 2008) . Other studies implicated altered microglia/macrophage response in reduced recovery after CNS injury in aged mice (Fenn et al., 2014; Sandhir et al., 2008 ), while we found increased upregulation of CD68, a marker for activated microglia and macrophages, following spinal cord injury in older mice when compared with young mice. Thus, increased astroglial and inflammatory responses along with fibrotic scarring (Hellal et al., 2011; Herrmann et al., 2010; Soderblom et al., 2013) may underlie, at least partially, the diminished effect on axon regeneration across and beyond the injury site in aging Pten-deleted mice. Future studies are required to pinpoint this mechanism.
In comparison to the CNS, axons in the peripheral nervous system (PNS) regenerate robustly. Nevertheless, a similar ageassociated decline in peripheral nerve regeneration exists (Verdú et al., 2000) . Recent studies attributed this age-associated decline in PNS regeneration to a slower clearance of nerve and myelin debris by Schwann cells (Kang and Lichtman, 2013; Painter et al., 2014) . Therefore, in both the mammalian PNS and CNS, neuron-extrinsic mechanisms appear to contribute to an age-dependent decline in axon regeneration after injury. As the older mice in our experiments ranged from 7-8 months to 12-18 months of age, our results have relevance not only to aging individuals but also to the middle-aged population in humans. This is especially important for therapeutic development, because although current preclinical models focus on young animals, the average age of incidence for spinal cord injury (as reported in the United States) is now at a middle age. Taking into consideration this age effect will be enormously important for mechanistic, preclinical, and future clinical studies to promote CNS repair in injury or disease. (Lesche et al., 2002) . AAV-Cre or control virus AAV-GFP was injected into the sensorimotor cortex of different age groups for the dorsal hemisection experimental groups, and AAV-Cre-GFP or AAV-GFP control was injected into the red nucleus for the dorsolateral funiculus crush groups (see Supplemental Experimental Procedures for details).
Corticospinal Tract Axotomy DH spinal cord injury was performed as described elsewhere Liu et al., 2010) , with minor modifications. Spinal cord injuries were performed 6 weeks after AAV injections in P1 mice and 4 weeks after AAV injections in mice of all other age groups. Surgeons were blind to the genotypes. After a T8 laminectomy, the dura was punctured bilaterally with a 30G needle. A pair of superfine iridectomy scissors was used to cut slightly over dorsal half of the spinal cord at a depth of 0.8 mm. A micro feather ophthalmic scalpel was used to retrace the lesion and ensure its completeness. The muscle layers were sutured and the skin was secured with wound clips and Dermabond.
Rubrospinal Tract Axotomy
Four weeks following red nucleus AAV injection, mice underwent a DLF crush at the level of the fourth cervical vertebra (C4) to unilaterally sever the rubrospinal tract similarly to as previously described (Hilton et al., 2013) . Briefly, a midline incision was made over the cervical vertebrae, and a C4 left hemilaminectomy was performed. The dura mater overlying the gray matter was pierced with a 26G needle, and fine-tipped Dumont #5 forceps with custom tips 200 mm in width were inserted, with one prong inserted into the dorsal horn gray matter to a depth of 1 mm and the other prong placed lateral to the dorsolateral funiculus. The forceps were closed and held for 15 s to sever the RST; the forceps were removed and inserted again in order to repeat this crush once. The muscles and skin were then closed with sutures and mice were permitted to recover in a heated incubator.
BDA Tracing of CST Axons
Two weeks before euthanasia (i.e., 4 weeks post-DH), mice received stereotaxic injection of BDA (10%, D1956; Invitrogen) to label CST axons by anterograde tracing. The same injection volumes and coordinates were used for BDA as for adult AAV injections (see above). For details on tissue processing, immunostaining, and quantification, please see Supplemental Experimental Procedures.
Statistics
Statistical tests were performed using GraphPad Prism version 6.0. Statistical significance was set at p < 0.05. Post hoc comparisons were carried out only when a main effect showed statistical significance. CST and RST regeneration data were analyzed using a two-way ANOVA followed by Bonferroni's post hoc test. Cell body data were analyzed using a one-way ANOVA followed by Bonferroni's post hoc test. Two-tailed Student's t tests were used for single comparisons between young versus aged mice. , and p-S6 (red) following AAV injection into the vicinity of the right red nucleus. These images show a more extended view of the panels shown in Figure 3A -C. Virus is taken up by a subset of neurons following injection. We quantified >200 NeuN+ neurons per red nucleus and >100 GFP+ NeuN+ neurons per right red nucleus per animal and confined analysis to magnocellular red nucleus (within 400 µm of the caudal pole). Pten f/f mice were injected with AAV-Cre-GFP or AAV-GFP (control) at 4 weeks or 7-8 months of age, subjected to dorsolateral funiculus (DLF) crush injury 4 weeks later, and euthanatized 8 weeks after injury. (E) Quantification of p-S6 intensity of rubrospinal neurons on the injured and AAV-injected side (ipsilateral) normalized to the uninjured red nucleus (contralateral). In a blinded fashion, soma area was measured based on NeuN+ immunoreactivity and then later denoted as GFP+ or GFP-based on co-labeling with GFP. For AAV-Cre-GFP injected mice, GFP+ neurons were considered Pten deleted, while GFP-neurons served as internal wild-type controls. Part of Figure 3G is duplicated in panel (E) here. (F) Quantification of average soma area of NeuN+ rubrospinal neurons after injury with and without Pten deletion. Sham, uninjured control. AAV-GFP control virus injection into the red nucleus of Pten f/f mice does not lead to Pten deletion. In AAV-Cre-GFP injected mice, GFP+ neurons had presumably undergone Pten deletion while GFP-neurons served as internal controls that presumably had not undergone Pten deletion. (G) Quantification of Soma Area Index (extending Figure 3H ) expressed as the ratio of the average cross sectional area of NeuN+ neurons in axotomized red nucleus over that of contralateral uninjured red nucleus. (F) and (G) represent two different ways to quantify the data, both leading to the same conclusion. Pten f/f mice were injected with AAV-Cre-GFP or AAV-GFP at 4 weeks or 7-8 months of age, subjected to DLF crush 4 weeks later, and euthanatized 8 additional weeks later. In a blinded fashion, soma area was measured based on NeuN+ immunoreactivity and then later denoted as GFP+ or GFP-based on co-labeling with GFP. In AAV-GFP injected control mice, axotomy significantly reduced soma size. This was also the case for GFP-neurons in the AAV-Cre-GFP injected red nuclei, which served as internal controls. Pten deletion prevented axotomyinduced soma size reduction of NeuN+ neurons (a soma size reduction is indicative of atrophy) in the red nucleus, irrespective of age. (H-I) Histogram of cross-sectional area plotting neurons in 100-µm 2 increments demonstrates a normalization of the distribution of cell sizes with Pten deletion. Note the predominance of small soma areas in GFP-neurons with AAV-Cre-GFP administration and GFP+ or GFP-neurons with AAV-GFP administration. Scale bar = 250 µm (A); 50 µm (B, C, D). One-way ANOVA followed by Bonferroni's post hoc test, *P < 0.05. Lower (A, B) and higher (C-G''') magnification representative images of coronal brain sections of control (Ctrl) or Pten-deleted (KO) mice in which Pten deletion was initiated at the indicated ages. Ipsi, ipsilateral, AAV-Cre injected side; contra, contralateral non-injected side. Boxes in (A, B) illustrate the areas corresponding to layer 5 sensorimotor cortex shown at a higher magnification in (C-G'''). PTEN f/f mice were injected unilaterally at P1, 4-6 weeks, 10 weeks or 12-18months of age in the right sensorimotor cortex with either AAV-Cre or AAV-GFP (as control). T8 dorsal hemisection (DH) injury was performed 4-6 weeks later; axon tracer BDA was injected in the right sensorimotor cortex 4 weeks after injury and mice perfused 2 additional weeks later. Sections were stained for p-S6 and NeuN. Unlike control AAV-GFP injected mice, AAV-Cre injected Pten-deleted mice exhibit substantial upregulation of p-S6 levels in cortical neurons on the injected side as compared with the contralateral side. In addition, the size of p-S6 expressing cells on the injected side was remarkably enlarged compared to controls. Observers blind to the experimental groups were able to distinguish (AAV-Cre injected) Pten deleted mice from (AAV-GFP injected) control mice unambiguously for every single animal based on p-S6 immunoreactivity and the soma size of p-S6 positive cells. However, no obvious difference was observed between the different Pten deleted age groups. It remains possible that other downstream effectors of mTOR besides p-S6 (e.g. 4E-BP) or other downstream effectors of the PI3K/Akt pathway besides mTOR (e.g. GSK-3) may be affected differently in young versus older Pten deleted neurons. Scale bar = 1 mm (a, b); 20 µm (C-G'''). (A-C) GFAP, CS-56 and Nogo-A immunoreactivity at different time points after injury at 100 µm around the lesion site. GFAP expression was robustly increased close to the injury site at all time points tested. At 21 days, whereas the old animal still presented a similar level of increased expression, it decreased in young animal close to the injury site and significant difference between young and old animals was observed on day 42. CS-56 expression was highly increased at 7 days after injury at and around the lesion site, gradually decreased over time but was still upregulated by 42 days. No statistical difference between young and old groups was observed. Nogo-A expression was upregulated around the injury at 7 days post injury and gradually decreased. No statistical difference between young and old groups was observed. Two 
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SUPPLEMENTAL EXPERIMENTAL PROCEDURES
Viral production and injection AAV-Cre and control AAV-GFP (Liu et al., 2010) were produced at the Salk Institute Viral Vector Core and reached a titer of 0.5×10 12 TU/ml and 0.7×10 12 TU/ml, respectively. For neonatal (P1) cortical injections, Pten f/f mice were cryo-anesthetized and injected unilaterally with 1 µl of either AAV-GFP or AAV-Cre into the right sensorimotor cortex using a modified 10 µl Hamilton syringe attached to a fine glass pipette. For adult cortical AAV injections, 4-6 week, 10 week or 12-18 month old Pten f/f mice were anesthetized with 2.5% Avertin (Sigma). 0.2 µl of AAV-GFP or AAV-Cre was injected into the right sensorimotor cortex at 6 different coordinates (coordinates from bregma: 0.1, 0.6 and 1.1 mm posterior; 1.0 and 1.4 mm lateral, 0.7 mm deep, total 1.2 µl/animal). By breeding the ROSA26-lsl-tdTomato reporter gene into Pten conditional mutant background, we estimated the AAV-Cre infection efficiency to be comparable between young (7-8 week old) and old (13 month old) mice based on the total number of CST axons labeled with tdTomato in the medulla (average for young Pten deleted mice: ~4300, n = 4; average for old Pten deleted mice: ~4000, n = 2).
For adult red nucleus injections, 4 week or 7-8 month old Pten f/f mice were injected with 0.5 µl of adenoassociated virus serotype 2 (AAV) encoding Cre and GFP or GFP only as control [Vector BioLabs; AAV2-Cre-GFP and AAV2-GFP, titer of 1 x 10 12 GC/ml] into the right red nucleus (coordinates from bregma: 3.5 mm posterior, 0.7 mm lateral, 3.5 mm ventral to the surface of the brain).
Tissue processing
Mice were perfused 6 weeks after DH injury (2 weeks after BDA injection) and 8 weeks after DLF crush. Tissue processing was performed as described with minor modifications (Geoffroy et al., 2015; Hilton et al., 2013; . After transcardial perfusion with 4% paraformaldehyde, brains and spinal cords were dissected out, and the tissues were post fixed overnight at 4°C in the same fixative solution. Tissues were incubated in sucrose for 3 days for cryo-protection. For dorsal hemisection groups, tissues were embedded in OCT compound, and snapped frozen on dry ice. An ~8 mm segment from 4 mm rostral and 4 mm caudal to the injury was embedded for sagittal sections; the spinal cord tissues just rostral and caudal to this 8 mm segment were embedded for transverse sections to evaluate axon labeling efficiency (based on the rostral tissue sections) and lesion completeness (based on the caudal tissue sections). Tissues were sectioned with a cryostat at 20 µm thickness for further processing. Floating step serial (every other) sagittal sections centered at the injury site were stained for BDA and GFAP. Medullae and brains were processed as described below. No statistically significant difference in lesion size was observed for any age group or genotype.
For DLF crush, tissues were snapped frozen in isopentane over dry ice. Cervical segments from C2 to C8 were cut into 20 µm longitudinal sections in the coronal (longitudinal) plane on a cryostat and stored at -80°C. Brain stem/midbrain from DLF crush groups were cut into 20 µm sections caudally to rostrally through the red nuclei. As the left and uninjured red nucleus was to be used as an internal control for immunoreactivity and area analyses, the tissue block was adjusted based on the appearance of the facial nuclei in order to achieve the correct left-right balance between left and right red nuclei.
Immunostaining
Medulla and spinal cord sections of the DH groups were incubated in Vectastain ABC solution (Vector Labs, PK-6100) overnight at 4°C, washed in PBS and mounted on gelatin-coated slides. BDA was detected with the TSA Plus Fluorescein System (10 min, room temperature, 1:200, Perkin Elmer, NEL741001KT). Sections were co-stained with polyclonal rabbit anti-GFAP (overnight incubation, 1:500, Dako, Z0334) after blocking in PBS with 0.4% Triton X-100 and 5% Horse Serum for 2 hours at room temperature. The next day, sections were washed and incubated with secondary anti-Rabbit Alexa Fluor 488 (Invitrogen, SA5-10038) for 1 hour at room temperature. After several washes with PBS, sections were cover-slipped with Fluoromount-G (Southern Biotech, OB100-01).
For the DLF crush groups, half of all longitudinal sections from each mouse were processed to visualize GFP+ RST axons by incubating sections overnight with antibodies specific to GFP (chicken α; Chemicon AB16901; 1:1000) and GFAP (DAKO Z0334; polyclonal Rabbit α; 1:1000).
For both DH and DLF crush groups, brain and spinal cord sections were incubated overnight with antibodies specific to NeuN (guinea pig α; Millipore ABN90P; 1:500), GFP (chicken α; Chemicon AB16901; 1:1000), Phospho-S6 (Rabbit α; Cell Signaling Ser235/236 2211S; 1:200), GFAP (Rat α; DAKO Z0334; 1:500), CS-56 (Mouse α; Sigma C8035; 1:100), CD68 (Rat α; AbD Serotec MCA1957; 1:400), Nogo-A (Rabbit α; in house; 1:500) Neurocan (Sheep α; R&D AF5800; 1:200), Sox9 (Goat α; R&D, AF3075, 1:200), Aldh1L1 (Rabbit α; Abcam, Ab87117, 1:1000, with HCl antigen retrieval) and/or C4S (Mouse α; MP Biochemicals 08636511; 1:800 with or without following a 2h digestion with Chondroitinase ABC, Sigma C2905) followed by appropriate Donkey α Guinea Pig Alexa Fluor 405 (706-156-148), Donkey α Chicken Alexa Fluor 488 (703-546-155), Donkey α Rabbit Alexa Fluor 594 (711-586-152), Donkey α Mouse546 (A10036) and Donkey α Rat 488 (A21208) for 2 hours as described (Geoffroy et al., 2015) .
Quantification
All quantifications were performed by observers blind to animal genotypes and age.
CST axon regeneration after dorsal hemisection. Images were taken with a digital camera mounted on a Zeiss epifluorescence microscope using the 10×, 20× or 100× (medulla only) objective lenses. Rostral to the injury site, the labeled axons were too numerous to count and we thus quantified the BDA labeling density, as described previously (Geoffroy et al., 2015) . A series of rectangles of 100 µm width covering the entire dorsoventral axis of the spinal cord were superimposed onto sagittal sections, starting from the injury site (delimited by GFAP staining) all the way to 1.5 mm rostral to the injury. After subtraction of the background, intensity was measured in every rectangle using ImageJ and normalized against the intensity at 1.5 mm rostral to injury. The ratio was taken as the rostral Axon Density Index and was plotted as function of the distance to the injury ( Figure 1E ). Caudal to the injury site, individual axons could be readily quantified at defined distances. The number of axons present in all regions containing BDA-labeled axons caudal to injury was quantified to assess regeneration. BDA-labeled axons exiting the GFAP sparse lesion core and entering the GFAP dense astroglial reactive area immediately caudal to the injury were considered regenerated. Vertical lines 100 µm apart were drawn caudal to the injury site covering the dorsoventral axis of the spinal cord, and the total number of axons between two adjacent lines was quantified. The axon numbers on every other sagittal section throughout the mediolateral axis were summed up, normalized against the total number of axons labeled in the medulla , and expressed as a function of the distance from the injury site to obtain the caudal Axon Number Index ( Figure 1G-H) . For this CST regeneration experiments, we quantified the following: N = 14 (P1 Ctrl); 8 (4-6 week Ctrl); 5 (12-18 month Ctrl), 11 (P1 KO); 14 (4-6 week KO);
